CEP
AMPH icon

Chicago Equity Partners’s Amphastar Pharmaceuticals AMPH Stock Holding History

Chicago Equity Partners’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-54,895
Closed -$796K – 746
2017
Q1 		$796K Sell
54,895
-47,525
-46% -$747K 0.02% 502
2016
Q4 		$1.89M Buy
102,420
+29,950
+41% +$583K 0.05% 344
2016
Q3 		$1.38M Buy
+72,470
New +$1.32M 0.04% 373

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Chicago Equity Partners's AMPH Position: Q2 2017 in Review

Chicago Equity Partners sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2017, closing a stake of 54,895 shares — an estimated $796K sold.

Chicago Equity Partners first reported a position in AMPH in Q3 2016 and held it in 3 quarters. The position peaked at $1.89M in Q4 2016. 108 funds tracked by Wall St. Rank hold AMPH as of Q2 2017.

  • Chicago Equity Partners reported no remaining Amphastar Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Chicago Equity Partners sold 54,895 Amphastar Pharmaceuticals shares in Q2 2017, an estimated $796K.
  • Chicago Equity Partners first reported a position in Amphastar Pharmaceuticals in Q3 2016 and held it in 3 quarters.
  • Chicago Equity Partners's Amphastar Pharmaceuticals position peaked at $1.89M in Q4 2016.
  • 108 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2017.

Based on Chicago Equity Partners's 13F filing for Q2 2017, filed 9 Aug 2017.